Skip to main content
. 2025 Apr 9;12:1559173. doi: 10.3389/fcvm.2025.1559173

Table 1.

Characteristics of reported cases of sintilimab-induced myocarditis in lung cancer patients.

Author, year Age/sex PT/stage ICI and Concomitant drugs Onset of myocarditis Clinical presentation ADR Diagnostic method Cardiac biomarkers ECG Treatment
Lin Y et al., 2022 66/M Ade/IV TC + Sintilimab 3 weeks after 1 cycle Chest pain, shortness of breath Myocarditis ECG, UCG, CAG TnI, CK, CK- MB, NT-proBNP↑ V5 - V9 ST↑ MP, IG
Chen X et al., 2024 33/F Ade/IV PC + Sintilimab 2 days after 3 cycles Shortness of breath, productive cough Myocarditis ECG, Chest CT α - HBDH, cTn, CK-MB, NT-proBNP↑ Tachycardia MP, De
Bi H et al., 2021 68/M SCC/Ⅲb TC + Sintilimab 6 days after 3 cycles Productive cough, progressive dysphagia Myocarditis ECG, CAG CK, CK-MB, hs-cTnl, BNP↑ CRBBB, Ⅱ°AVB, diffuse ST segment depression MP
Xing Q et al., 2020 68/M Ade/NA Sintilimab 4 days after 2 cycles Fatigue, myalgia, shortness of breath, progressive muscle weakness Myocarditis, myositis, rhabdomyolysis ECG, UCG CPK, Myo, TnT, anti-AChR-Ab↑ CRBBB, Ⅲ°AVB MP, IG, Mestinon, PE, TPM
Xia J et al., 2024 66/M Ade/IVb PN + Sintilimab 2 weeks after 2 cycles Double eyelid ptosis, chest tightness Myocarditis, hepatitis, pneumonia ECG, UCG, CTA, Chest CT CK-MB, Myo, ultra-TNI, NT-proBNP, AST, ALT↑ CRBBB, LAH, LAD, ST-T changes MP, IG
Hu Y et al., 2023 60/M SCC/ⅠA3 TC + Sintilimab after 2 cycles No symptoms Myocarditis CTA, ECG, UCG, CMR, Chest CT, myocardial biopsy TnT, NT-proBNP↑ Normal sinus rhythm MP
Zhang Y et al., 2023 58/M Ade/IVb PC + Sintilimab after 1cycle No symptoms Myocarditis, myasthenia gravis, myositis ECG, UCG, CAG, MPI, CMR, EMG hsTNI, CK, CK-MB, Myo↑ Sinus rhythm, type A pre-excitation syndrome MP
The present case report 71/M SCC/T4N3Mx G + Sintilimab 17 days after 1cycle Shortness of breath, cough, yellow sputum, fatigue, bilateral knee pain Myocarditis ECG, UCG, CAG BNP, CK-MB, ultra-Tnl, Myo↑ Abnormal Q waves, ST-segment elevation MP, IG

PT, pathological types; ICI, immune checkpoint inhibitors; M, male; Ade, adenocarcinoma; ECG, electrocardiograph; UCG, ultrasonic cardiogram; CAG, coronary arteriography; CMR, cardiac magnetic resonance; F, female; CTA, computed tomography angiography; SCC, squamous cell carcinoma; IG, immunoglobulin; MP, methylprednisolone; CRBBB, complete right bundle branch block; AVB, atrioventricular block; LAH, left anterior hemiblock; LAD, left axis deviation; PE, plasma exchange; ST, sinus tachycardia; APB, atrial premature beats; AT, atrial tachycardia.